BRASKEM SA (BAK): Financial results for Q3 2026

BRASKEM SA (BAK) furnished an SEC Form 6-K — earnings release. CONTENTS 1. OPERATIONAL AND FINANCIAL INDICATORS 6 2. EXECUTIVE SUMMARY 3Q26 7 3. PERFORMANCE BY SEGMENT 3Q26 8 3.1 BRAZIL/SOUTH AMERICA 8 3.1.2 OVERVIEW 9 3.2 RENEWABLES OVERVIEW 13 3.3 UNITED STATES AND EUROPE 14 3.4 MEXICO 16 4. CONSOLIDATED FINANCIAL OVERVIEW 18 4.1 CONSOLIDA

Event · Earnings
Original reporting
Published Nov 13, 2026, 11:08 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 13, 2026, 11:12 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$BAK
Bearish
high confidence
Mentioned
$BAK
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 6-K
Decision brief

The 30-second read

$BAKBearishHigh
01

Why it matters

The earnings miss is likely to trigger a sell‑off in the stock and could influence sentiment across the broader petrochemical sector.

02

Market read

Fresh earnings data with a significant EBITDA decline makes this a high‑impact news item for traders focused on chemicals and emerging market equities.

03

What to watch

The release notes a strategic expansion in priority markets and a strong cash generation from working‑capital changes, which may support longer‑term earnings recovery.

Relevance 7/10Novelty 8/10Timing: pre‑market today
AlphAI · Earnings readBAK · Q3 2026 · ended 2026-09-30

Braskem 3Q26 Recurring EBITDA of US$382 million, 63% lower than 2Q26 as international petrochemical spreads normalized; net loss attributable to shareholders of US$206 million

↓Weak quarter

Consolidated Recurring EBITDA fell 63% sequentially in US dollars to US$382 million, the company reports a net loss attributable to shareholders of US$206 million, leverage is 6.36x, and the filing shows Fitch at RD and S&P at D on the global scale. Operating cash generation of R$2.2 billion was driven mainly by working capital, including a trade credit limit used for Petrobras feedstock purchases, rather than by operating earnings.

Revenue
$9M
-41% vs the same effect in 2Q26 q/q
Brazil/South America
Not printed as a figure in filing text

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
Consolidated Recurring EBITDA, 3Q26non-GAAPUS$382 million (R$1,961 million)-63% in US$; -63% in R$ (vs 2Q26)+154% in US$; +140% in R$ (vs 3Q25)
Brazil/South America Recurring EBITDA, 3Q26non-GAAPUS$267 million (R$1.4 billion)-69% in US$; -69% in R$ (vs 2Q26)+30% in US$; +23% in R$ (vs 3Q25)
United States and Europe Recurring EBITDA, 3Q26non-GAAPUS$15 million (R$78 million)-90% in US$; -89% in R$ (vs 2Q26)higher by US$30 million (R$157 million) (vs 3Q25)
Mexico (Braskem Idesa) Recurring EBITDA, 3Q26non-GAAPUS$2 million (R$11 million)-96% in US$; -96% in R$ (vs 2Q26)higher by US$39 million (R$215 million) (vs 3Q25)
Consolidated gross profit change, 3Q26 vs 2Q26non-GAAPnot printed as a level figure in filing textdecrease of US$665 million (R$3,312 million) vs 2Q26increase of US$311 million (R$1,567 million) vs 3Q25
Net income (loss) attributable to shareholders, 3Q26GAAPnet loss of US$206 million (R$1.1 billion)––
Negative foreign exchange variation, 3Q26GAAPUS$19 million (R$100 million)––
Consolidated financial expenses, 3Q26GAAPnot printed as a figure in filing text+10% (vs 2Q26)+11% (vs 3Q25)
Consolidated financial income, 3Q26GAAPnot printed as a figure in filing text+5% (vs 2Q26)-28% (vs 3Q25)
Consolidated other income (expenses), net, 3Q26GAAPnet expense of R$8 million––
COGS benefit from REIQ Raw Materials PIS/COFINS credits, 3Q26otherUS$92 million (R$472 million)US$20 million (R$103 million) lower than 2Q26–
Brazil/South America presumed PIS/COFINS credits in net revenue (REIQ Investimentos), 3Q26otherUS$9 million (R$48 million)-41% vs the same effect in 2Q26–
Brazil/South America net revenue excluding REIQ effect, 3Q26GAAPnot printed as a figure in filing text-10% in US$; -8% in R$ (vs 2Q26)+19% in US$; +12% in R$ (vs 3Q25)
United States and Europe net revenue, 3Q26GAAPnot printed as a figure in filing text-24% in US$; -22% in R$ (vs 2Q26)+18% in US$; +12% in R$ (vs 3Q25)
Mexico net revenue, 3Q26GAAPnot printed as a figure in filing text-7% in US$; -5% in R$ (vs 2Q26)+30% in US$; +23% in R$ (vs 3Q25)
Green PE and ETBE net sales revenue (Renewables), 3Q26othernot printed as a figure in filing text+1% (vs 2Q26)+3% (vs 3Q25)
Operating cash generation, 3Q26otherR$2.2B––
Cash generation before debt, 3Q26otherR$2B––
Corporate investments, 3Q26 (ex-Braskem Idesa and ex-REIQ)otherUS$125 million (R$645 million)––
Revised 2026 corporate investment plan (ex-Braskem Idesa and ex-REIQ)otherUS$496 million (R$2.7 billion)––
Braskem Idesa 2026 planned investmentsotherUS$42 million (R$234 million)––
Corporate gross debt, 30 Sep 2026other$10.9B––
Adjusted net debt, 30 Sep 2026non-GAAP$9.9B+5%–
Corporate financial leverage, 30 Sep 2026other6.36x––
Alagoas geological event provision balance, 30 Sep 2026otherR$3.19B––

Segments

SegmentRevenueq/qy/y
Brazil/South AmericaRecurring EBITDA of US$267 million (R$1.4 billion), down 69% vs 2Q26 in US$ and R$, mainly due to normalization of average international spreads for resins and main chemicals (company explanation), partly offset by higher resin sales volume in Brazil and higher resin and main chemicals exports. Up 30% vs 3Q25 in US$ and 23% in R$, mainly due to higher average international spreads and higher volumes. Net revenue excluding REIQ effect was -10% in US$ and -8% in R$ vs 2Q26, and +19% in US$ and +12% in R$ vs 3Q25. COGS was positively impacted by REIQ Raw Materials credits of US$92 million (R$472 million).Not printed as a figure in filing text––
United States and EuropeRecurring EBITDA of US$15 million (R$78 million), down 90% vs 2Q26 in US$, mainly explained by a 14% decrease in the average international PP spread and lower PP sales volume (company explanation). Up by US$30 million (R$157 million) vs 3Q25, mainly due to the higher average international PP spread. Other income (expenses) was a net expense of US$14 million (R$73 million), mainly due to an inventory write-off of spare parts. PP demand was +2% in North America and -4% in Europe vs 2Q26.Not printed as a figure in filing text––
Mexico (Braskem Idesa)Braskem Idesa Recurring EBITDA of US$2 million (R$11 million), down 96% vs 2Q26 in US$ and R$, mainly due to a 35% decrease in the average international PE spread, partly offset by higher PE sales volume (+34 thousand tons, +28%) from higher utilization (company explanation). Up by US$39 million (R$215 million) vs 3Q25. SG&A rose vs 2Q26 and 3Q25, mainly explained by higher third-party service expenses (company explanation).Not printed as a figure in filing text––
Renewables (Green PE and ETBE)Net sales revenue of Green PE and ETBE was in line with 2Q26 (+1%). Compared to 3Q25 it was higher (+3%), mainly explained by the increase in higher-value-added sales (company explanation).Not printed as a figure in filing text+1%+3%

Capital returns

  • The filing text reports no dividend, interest-on-capital or share repurchase figures for 3Q26.
  • The 2026 corporate investment plan (ex-Braskem Idesa and ex-REIQ) was revised to US$496 million (R$2.7 billion) under the Operational Excellence 360 Program launched in the quarter.
  • Braskem Idesa's planned 2026 investments total US$42 million (R$234 million).

What drove it

  • Company explanation: the Middle East conflict resolution expectation and a more moderate global demand environment lowered feedstock prices, normalizing petrochemical spreads toward pre-conflict levels after the 2Q26 peak.
  • Company explanation: Recurring EBITDA decline reflects the decrease of US$665 million (R$3,312 million) in consolidated gross profit vs 2Q26, including lower international spreads for resins (-42%), main chemicals (-13%), PP in the US and Europe (-14%) and PE in Mexico (-35%).
  • Company explanation: commercial strategy to expand market share in priority segments added resin sales volume in Brazil (+91 thousand tons, +12%), resin exports (+65 thousand tons, +37%), main chemicals exports (+7 thousand tons, +11%) and Mexico PE sales volume (+34 thousand tons, +28%) vs 2Q26.
  • Company explanation: net loss of US$206 million was mainly due to lower gross profit from normalized spreads and a negative foreign exchange variation of US$19 million (R$100 million).
  • Company explanation: financial expenses rose vs 2Q26 mainly due to higher interest on US dollar-denominated obligations and present value adjustment expenses on Alagoas disbursements. Vs 3Q25 the increase reflects the US$1.0 billion drawdown of the stand-by credit facility.
  • Company explanation: Brazil/South America COGS benefited from REIQ Raw Materials credits of US$92 million (R$472 million), which were US$20 million (R$103 million) lower than in 2Q26 mainly due to lower naphtha and propane prices.

Concerns

  • Consolidated Recurring EBITDA of US$382 million fell 63% vs 2Q26 in US$ and R$.
  • Net loss attributable to shareholders of US$206 million in 3Q26.
  • Corporate leverage of 6.36x and adjusted net debt of US$9.9 billion, up 5% vs the previous quarter.
  • Fitch rates Braskem RD (global) and S&P rates Braskem D (global); Braskem Idesa is rated D by both Fitch and S&P.
  • United States and Europe Recurring EBITDA fell 90% vs 2Q26 to US$15 million, and Mexico Recurring EBITDA fell 96% to US$2 million.
  • Other income (expenses) included write-offs: a US$14 million expense in the US and Europe segment and approximately US$10 million from spare parts in the consolidated net expense of R$8 million.
  • The filing states that the number of Alagoas-related claims, their nature and amounts cannot be estimated, and that expenses may significantly differ from estimates and provisions.
  • The filing states that Braskem continues to face and could still face administrative procedures and lawsuits related to Alagoas.

What to watch

  • Recurring EBITDA recovery as the international spreads for resins, PP and PE evolve after normalization.
  • The Brazilian resin demand trend, which the filing describes as in line with 2Q26, and the inventory positions in the transformation chain.
  • Repayment of the working capital benefits (Petrobras trade credit limit of approximately R$1.6 billion and R$475 million inventory effect), which the filing shows as contributors to 3Q26 cash generation.
  • Leverage of 6.36x and the path of corporate gross debt of US$10.9 billion.
  • Ratings actions and the outcome of Braskem Idesa's TQPM support obligations and collateral perfection.
  • Alagoas: the provision balance of R$3,195 million, the Environmental Diagnosis update planned for 2027, progress on the Flexal and socio-urban actions, and developments in the Federal criminal proceeding (charges accepted by the court in June 2026, responses submitted in September 2026).
  • Implementation of the Operational Excellence 360 Program and the revised corporate investment plan of US$496 million.

Balance sheet and cash flow

  • Operating cash generation was R$2.2 billion in 3Q26, mainly due to a positive change in working capital of approximately R$1.0 billion.
  • Trade payables contributed approximately R$1.5 billion, mainly explained by the trade credit limit for feedstock purchases from Petrobras of approximately R$1.6 billion (company explanation).
  • Inventories contributed R$475 million, which the company attributes to the market share strategy.
  • Taxes payable and recoverable contributed R$381 million, attributed to participation in the State of São Paulo ICMS installment program and the monetization of CIDE-Fuel tax credits.
  • Cash generation before debt totaled R$2.0 billion after other effects and disbursements related to the Alagoas geological event.
  • Corporate gross debt was US$10.9 billion at 30 September 2026, including the drawdown of the stand-by credit facility carried out in October 2025. From 2Q26 gross debt includes lease liabilities.
  • Adjusted net debt was US$9.9 billion, an increase of 5% vs the previous quarter, due to the reclassification of letters of credit from Suppliers to Loans and Financing in the amount of US$424 million (R$2.1 billion).
  • Corporate leverage ended the quarter at 6.36x.
  • Fitch rates Braskem RD on the global scale and RD (bra) on the national scale (dated 14 August 2026). S&P rates Braskem D on the global scale and brD on the national scale (dated 26 June 2026).
  • Fitch rates Braskem Idesa D (dated 18 August 2026). S&P rates Braskem Idesa D (dated 20 November 2025).
  • Braskem Idesa changed its functional currency from the Mexican peso to the US dollar on 30 June 2026, based on management's assessment of its ethane supply matrix and higher share of US dollar-denominated exposures.
  • Net foreign exchange variation was negative, primarily explained by an approximately 0.1% depreciation of the Brazilian real applied to average net exposure of US$10.3 billion (Company) and US$4.3 billion (Braskem Idesa and subsidiaries).
  • Under the TQPM financing, Braskem's capital support covers 50% of the outstanding balance of Terminal Química as of end-September 2026, with the remaining 50% guaranteed by the other TQPM shareholder until the collateral perfection date.
  • The Alagoas provision balance was R$3,195 million at 30 September 2026, down from R$3,247 million at 30 June 2026. 3Q26 payments and reclassifications were R$173 million.
  • Of the R$1.2 billion State of Alagoas agreement, R$139 million (adjusted to current value) has been paid. The outstanding balance is expected to be paid in 10 variable, adjusted annual installments, mainly after 2030.

Analysis

Braskem reported consolidated Recurring EBITDA of US$382 million (R$1,961 million) for 3Q26, down 63% from 2Q26 in both US dollars and reais, and up 154% in US dollars against 3Q25. The company attributes the sequential decline to the normalization of international petrochemical spreads after the 2Q26 peak, as feedstock prices eased on expectations of a resolution to the Middle East conflict and a more moderate global demand environment. Consolidated gross profit fell by US$665 million (R$3,312 million) vs 2Q26, while it rose by US$311 million (R$1,567 million) vs 3Q25. Gross profit is the line the filing cites as the main driver of both the sequential and year-on-year changes.

Segment results diverge sharply. Brazil/South America delivered Recurring EBITDA of US$267 million (R$1.4 billion), down 69% sequentially but up 30% vs 3Q25, supported by higher resin sales volume in Brazil (+91 thousand tons vs 2Q26) and higher resin exports (+65 thousand tons). United States and Europe fell to US$15 million (R$78 million), with the company citing a 14% lower average international PP spread and lower PP sales volume. Mexico (Braskem Idesa) fell to US$2 million (R$11 million), which the company links to a 35% lower average international PE spread, partly offset by PE volume up 28% on higher utilization. Volume growth in Brazil and Mexico was not enough to offset the spread compression in the quarter.

Below EBITDA, the company reports a net loss attributable to shareholders of US$206 million (R$1.1 billion), attributed in the filing to lower gross profit and a negative foreign exchange variation of US$19 million (R$100 million). Financial expenses rose 10% sequentially and 11% vs 3Q25, with the company pointing to interest on US dollar obligations, the US$1.0 billion stand-by credit drawdown, and present value adjustments on Alagoas disbursements. Other income (expenses) were a net expense of R$8 million, including inventory write-offs of spare parts in the United States and a partial reversal in Mexico.

Cash performance was stronger than earnings. Operating cash generation was R$2.2 billion, but the company states that about R$1.0 billion of this came from working capital, including a trade credit limit used for Petrobras feedstock purchases (about R$1.6 billion) and a R$475 million inventory effect. Cash generation before debt was R$2.0 billion. Corporate gross debt stood at US$10.9 billion and adjusted net debt at US$9.9 billion, up 5% sequentially after a US$424 million reclassification of letters of credit. Corporate leverage ended at 6.36x. The company revised its 2026 corporate investment plan to US$496 million (R$2.7 billion) under the Operational Excellence 360 Program.

Credit and legal matters weigh heavily on the read. Fitch rates Braskem RD and S&P rates it D on the global scale, and Braskem Idesa is rated D by both agencies. The Alagoas provision stood at R$3,195 million at 30 September 2026, down from R$3,247 million at 30 June 2026, and the filing states that future costs may differ significantly from estimates. No guidance, dividend or repurchase figures are printed in this filing, so the forward view rests on the qualitative statements about spreads, demand and the investment plan.

Not in the filing

stated, not guessed
  • Prior-quarter (2Q26) and prior-year (3Q25) absolute values for consolidated Recurring EBITDA, segment Recurring EBITDA in US$ and R$, and net income; the filing prints only percentage or amount changes for these lines.
  • Consolidated total revenue (net revenue) figure for 3Q26 and its prior-period comparatives; the consolidated revenue table is an image not present in the text.
  • Segment net revenue figures for Brazil/South America, United States and Europe, Mexico, and Renewables; only percentage changes are printed.
  • Consolidated cost of goods sold, gross profit level, SG&A total, and other operating expense totals as absolute figures.
  • Operating income, EBIT, EPS (GAAP and non-GAAP), income tax and interest expense as absolute values.
  • Financial expense and financial income absolute amounts.
  • Free cash flow and capital expenditure totals for the consolidated company.
  • Total assets, total equity and cash balance at 30 September 2026.
  • Dividend, interest-on-capital and share repurchase amounts (none printed).
  • Guidance or outlook for 2026 or subsequent periods (none printed in the text).
  • Previous-period outlook (not provided), so vs_prior_guidance is empty.
  • Consensus estimates and share price reaction (not provided in the documents).
  • Named executive quotations: the only signed name is the CFO's signature block, which is not a quote.
  • Period end date is taken from the filing's references to 'the third quarter of 2026' and 'as of September 30, 2026'.

Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Background

The filing is Braskem's first public earnings disclosure for Q3 2026, submitted via SEC Form 6‑K, providing the latest financial metrics and forward‑looking statements.

Company-level read

Ticker impact

$BAKBearishHigh confidence
Context

Braskem SA disclosed Q3 2026 recurring EBITDA of $382 million, a 63% YoQ decline, and cash generation of R$2.2 billion in its earnings release.

Expected impact

downward pressure as investors price in lower EBITDA and higher leverage

Evidence & confidence

The sharp EBITDA decline and higher debt ratio signal weaker profitability, which typically triggers sell‑offs in the short term.

Market effects

Petrochemical spreads normalization may affect peers in the chemicals sector, potentially easing margin pressure for other resin producers.

Brazilian and Latin‑American markets could see broader sentiment shifts as the region's largest resin maker reports weaker results.

Global petrochemical pricing dynamics are highlighted, but the direct impact is limited to Braskem and its immediate competitors.

Counterpoint

If the market overreacts to the EBITDA drop, a bounce could occur once the company’s share‑gain initiatives materialize.

Key entities

  • Braskem SA

    Largest resin producer in the Americas, listed on NYSE as BAK.

Every BAK earnings report

This story covers one filing. The ticker page keeps them all: each quarter's reported metrics with year-over-year and sequential comparisons, segments, guidance, and how the numbers landed against the company's own prior outlook.

Related articles

$BAKMed

Braskem Loss Hits US$189M as Creditors Wait

Braskem, a Brazilian resin producer, reported a R$1.07 billion (US$189 million) loss in Q3 2026, citing narrower spreads and high financing costs. Net revenue rose 13% to R$19.58 billion (US$3.46 billion). Creditors have not agreed to a debt deal, and auditor Deloitte noted material uncertainty about the company's ability to continue as a going concern.

$BAKMed

Braskem Q3 Earnings Call Highlights

Braskem (NYSE:BAK) is pursuing a capital structure solution with advisers and interested parties, according to CFO Carlos Brandão. The company is focused on reaching agreement on essential commercial terms. Braskem expects modest recovery in Q4 spreads, with increases forecasted for Brazil's polyethylene, polypropylene, and Mexico's polyethylene-ethane spreads. The company reported a BRL 3.2 billion provision balance for a geological event in Alagoas, with 99.9% of relocation completed.

$BAKMed

Braskem Loses US$189M as Debt Talks Drag On

Braskem, the largest resin producer in the Americas, reported a net loss of R$1.07 billion (US$189 million) in Q3 2026, reversing a profit from the previous quarter. The loss was driven by lower gross profit due to narrowed chemical and petrochemical spreads. The company's recurring EBITDA fell 63% to R$1.96 billion (US$347 million), while net revenue increased 13% year-over-year to R$19.58 billion (US$3.46 billion).